Published in Women's Health Law Weekly, August 30th, 2009
"The aflibercept, or VEGF-Trap, molecule is the subject of this article, Its molecular structure, pharmacokinetic and pharmacodynamic profile, and preclinical and early clinical data in epithelial ovarian carcinoma is reviewed. For comparison, other...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly